Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,112
Closed -$481K 359
2026
Q1
$481K Sell
17,112
-683
-4% -$18.2K 0.05% 254
2025
Q4
$443K Buy
17,795
+1,530
+9% +$38.6K 0.05% 243
2025
Q3
$414K Buy
16,265
+1,829
+13% +$45.1K 0.05% 247
2025
Q2
$350K Buy
14,436
+5,121
+55% +$119K 0.04% 250
2025
Q1
$236K Sell
9,315
-45,340
-83% -$1.19M 0.03% 259
2024
Q4
$1.45M Sell
54,655
-10,283
-16% -$279K 0.18% 86
2024
Q3
$1.88M Sell
64,938
-20
-0% -$583 0.23% 73
2024
Q2
$1.83M Sell
64,958
-563
-0.9% -$15.5K 0.2% 73
2024
Q1
$1.82M Buy
65,521
+29,118
+80% +$808K 0.22% 75
2023
Q4
$1M Sell
36,403
-1,740
-5% -$52.6K 0.13% 99
2023
Q3
$1.27M Buy
38,143
+1,747
+5% +$61.8K 0.18% 79
2023
Q2
$1.33M Buy
36,396
+334
+0.9% +$13K 0.19% 65
2023
Q1
$1.4M Buy
36,062
+3,717
+11% +$161K 0.22% 63
2022
Q4
$1.43M Sell
32,345
-5,052
-14% -$242K 0.22% 62
2022
Q3
$1.56M Buy
37,397
+906
+2% +$44K 0.27% 48
2022
Q2
$1.82M Sell
36,491
-886
-2% -$45.1K 0.28% 46
2022
Q1
$1.82M Buy
37,377
+1,050
+3% +$54.5K 0.3% 52
2021
Q4
$1.7M Buy
36,327
+24,424
+205% +$1.21M 0.27% 51
2021
Q3
$512K Sell
11,903
-283
-2% -$12.5K 0.08% 107
2021
Q2
$492K Sell
12,186
-237
-2% -$9.22K 0.08% 108
2021
Q1
$480K Sell
12,423
-3,362
-21% -$119K 0.08% 110
2020
Q4
$581K Buy
15,785
+1,539
+11% +$56.5K 0.11% 88
2020
Q3
$492K Buy
14,246
+1,268
+10% +$44.5K 0.11% 78
2020
Q2
$415K Buy
12,978
+1,253
+11% +$42.6K 0.12% 82
2020
Q1
$353K Buy
+11,725
New +$400K 0.15% 63
2019
Q1
Sell
-7,239
Closed -$300K 83
2018
Q4
$300K Buy
+7,239
New +$301K 0.17% 37

Other funds holding PFE

INVST's PFE Position: Q2 2026 in Review

INVST sold out of Pfizer (PFE) in Q2 2026, closing a stake of 17,112 shares — an estimated $481K sold.

INVST first reported a position in PFE in Q4 2018 and held it in 26 quarters. The position peaked at $1.88M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • INVST reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • INVST sold 17,112 Pfizer shares in Q2 2026, an estimated $481K.
  • INVST first reported a position in Pfizer in Q4 2018 and held it in 26 quarters.
  • INVST's Pfizer position peaked at $1.88M in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.